DSIP vs Selank: Sleep vs Anxiety — Which Peptide for Which?
Here is how these two compounds compare — based on published research, not marketing claims.
DSIP
518
Indexed Studies
Human Trials
Evidence Level
Yes
Human Trials
Not Approved
FDA Status
Selank
88
Indexed Studies
Human Trials
Evidence Level
Yes
Human Trials
Not Approved
FDA Status
PSI OVERVIEW
Here is the key difference between these compounds and what it means for the research.
DSIP and selank both appear in conversations about relaxation, but they target different problems. DSIP was discovered for its ability to induce delta sleep — the deepest, most restorative phase. Selank was developed as an anxiolytic — it reduces anxiety through GABA and serotonin modulation. One is a sleep peptide. The other is an anxiety peptide. They overlap because relaxation helps both sleep and anxiety, but the primary mechanisms differ.
Key Differences
| Attribute | DSIP | Selank |
|---|---|---|
| Evidence Level | Animal Studies | Animal Studies |
| Category | Neuropeptide | Anxiolytic Peptide |
| Human Data | Several older human studies showing sleep architecture changes. PSI rates L2. | Russian clinical approval. Some published human studies. PSI rates L2. |
| Safety Profile | Limited safety data. Research dates back to the 1970s. No serious adverse events in published studies. Not FDA-approved. | Approved in Russia for anxiety. Reported as well-tolerated with no dependence liability. Limited Western safety data. |
| Key Limitations | Much of the research is decades old. Limited modern replication. Mechanism not fully elucidated. | Most evidence in Russian literature. Limited independent Western replication. |
Mechanism Comparison
HOW THEY WORK
These compounds work through different biological pathways. Here is how each one operates at the cellular level.
DSIP
Modulates sleep-wake signaling in the brain, particularly delta wave sleep architecture. Also affects stress hormone regulation and pain modulation. Think of it as tuning the brain's sleep radio to the deepest, most restorative frequency.
Selank
Modulates GABA-ergic signaling and the enkephalin system. Reduces anxiety without sedation or dependence — unlike benzodiazepines. Also influences serotonin metabolism and BDNF expression.
DSIP works on sleep architecture — it modulates the electrical patterns in your brain during sleep, particularly the slow delta waves associated with deep restoration. Selank works on anxiety neurotransmission — it adjusts the GABA and serotonin balance to reduce the neurological basis of anxiety. DSIP targets what happens when you sleep. Selank targets what keeps you awake.
Research Evidence
RESEARCH EVIDENCE
Between these compounds, researchers have published over 606 indexed studies. Here are the key findings.
Both L2. DSIP has older research with interesting but unreplicated sleep findings. Selank has Russian regulatory approval and more consistent research output. Neither has robust Western clinical validation.
For sleep quality specifically, DSIP has the more directly relevant mechanism.
For anxiety that affects sleep, selank addresses the root cause (anxiety) rather than the symptom (poor sleep).
For daytime anxiety without sedation, selank is the more appropriate compound.
For circadian rhythm disruption, DSIP has specific research on sleep-wake regulation.
Key Limitations
- •No head-to-head comparison.
- •Both are L2 with limited Western clinical data.
- •DSIP research is largely from the 1970s-1990s with limited replication.
- •Selank research is concentrated in Russian-language literature.
PSI Verdict
SUPPORTED BY EVIDENCE
DSIP modulates delta sleep architecture in human studies. Selank reduces anxiety through GABA modulation without sedation or dependence, supported by Russian clinical approval.
NOT YET ESTABLISHED
Neither has robust modern clinical trial data by Western standards. DSIP's mechanism of action is not fully understood. Whether selank's anxiolytic effects replicate consistently outside Russian clinical settings is unconfirmed.
CONFIDENCE LEVEL
Low-moderate for both. Selank has a slight edge due to regulatory approval in one country. DSIP has interesting but old and unreplicated data. Neither is a confident clinical recommendation.
Community Discussion
WHAT THE COMMUNITY IS SAYING
PSI monitors discussions across peptide research and biohacking communities. These are reported experiences, not clinical evidence.
DSIP
"DSIP gave me the best sleep of my life"Plausible but limited human data
"DSIP is not a sleeping pill — it regulates sleep naturally"Plausible distinction
Selank
"Selank eliminated my anxiety without the side effects of benzodiazepines"Plausible but unproven
"Nasal spray is the best way to take it"Supported by published data
"It stacks well with Semax for cognitive performance"Anecdotal only
Safety Comparison
SAFETY PROFILE
What is currently known about the safety of each compound based on available research.
DSIP
Limited safety data. Research dates back to the 1970s. No serious adverse events in published studies. Not FDA-approved.
Selank
Approved in Russia for anxiety. Reported as well-tolerated with no dependence liability. Limited Western safety data.
Selank has Russian regulatory approval and more clinical use history. DSIP has older studies with no serious safety signals. Neither has extensive modern safety characterization.
WHAT THE RESEARCH SUGGESTS
Different tools for different problems. DSIP for sleep. Selank for anxiety. If anxiety causes sleep problems, selank targets the root. If sleep is the primary issue regardless of anxiety, DSIP is more specific.
Frequently Asked Questions
Explore Each Compound
For the full evidence profile, PSI Verdict, and indexed research data, visit each compound's dedicated page.
Looking for a physician experienced with peptide therapy?
Every physician in the PSI directory is individually verified for active licensure, board certification, and clinical peptide experience.
Browse the PSI Physician Directory →Explore Individual Research Pages
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.